Drugs for Abnormality of Glucagon Secretion (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 10)
| # |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
| 1 |
|
Gastrointestinal Agents |
|
Early Phase 1 |
|
|
|
| 2 |
|
glucagon |
|
Early Phase 1 |
|
|
|
| 3 |
|
Glucagon-Like Peptide 1 |
|
Early Phase 1 |
|
|
|
| 4 |
|
Hormone Antagonists |
|
Early Phase 1 |
|
|
|
| 5 |
|
Hormones |
|
Early Phase 1 |
|
|
|
| 6 |
|
Hormones, Hormone Substitutes, and Hormone Antagonists |
|
Early Phase 1 |
|
|
|
| 7 |
|
Hypoglycemic Agents |
|
Early Phase 1 |
|
|
|
| 8 |
|
Incretins |
|
Early Phase 1 |
|
|
|
| 9 |
|
insulin |
|
Early Phase 1 |
|
|
|
| 10 |
|
Insulin, Globin Zinc |
|
Early Phase 1 |
|
|
|
Interventional clinical trials:
| # |
Name |
Status |
NCT ID |
Phase |
Drugs |
| 1 |
Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes |
Unknown status |
NCT02398383
|
Early Phase 1 |
|
|
